Skip to main content
RIGL filings

Corporate insider profile

Kamil Ali-Jackson Filing Activity

Latest reported as Director of RIGEL PHARMACEUTICALS INC (RIGL).

Purchase filings
0
Reported companies
1
Net open-market value
-$160,425.00
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026RIGEL PHARMACEUTICALS INC (RIGL)DirectorSale2,500$35.00$87,500
May 26, 2026RIGEL PHARMACEUTICALS INC (RIGL)DirectorSale2,500$29.17$72,925